What is hip osteoarthritis?
Hip osteoarthritis is a degenerative joint condition involving progressive cartilage loss within the hip joint, accompanied by changes to the underlying bone and surrounding structures. Over time, this can result in joint space narrowing, osteophyte formation, and reduced joint mobility. Although often labelled as βwear and tearβ, hip osteoarthritis is influenced by multiple factors including joint shape, previous injury, muscle strength, activity patterns, and body weight. The severity of symptoms does not always correlate closely with imaging findings, making clinical assessment essential.
Symptoms and functional impact?
Typical symptoms include deep groin pain, stiffness (particularly after rest), reduced hip movement, and pain radiating to the thigh or knee. Patients often notice difficulty with walking distances, climbing stairs, standing from low chairs, or performing activities such as dressing. As symptoms progress, hip osteoarthritis can significantly limit independence and physical activity, with knock-on effects on general health and wellbeing. Sudden worsening of pain or mechanical symptoms should prompt reassessment to exclude alternative pathology.
Assessment and diagnosis
Diagnosis is based on a detailed history and physical examination, focusing on pain location, movement restriction, gait, and functional limitation. Plain X-ray imaging is commonly used to confirm osteoarthritic changes and assess severity. MRI is reserved for selected cases where symptoms are atypical or additional pathology is suspected. At Northern Medical Practitioners, assessment emphasises functional impact and clinical findings rather than imaging alone, as this more reliably guides management decisions.
Treatment options
Initial management focuses on conservative strategies including activity modification, targeted exercise and strengthening programmes, weight management where appropriate, and analgesia. For selected patients with persistent symptoms, image-guided injection treatments may be considered to provide symptom relief. These can include corticosteroid injections and, in carefully selected cases, biologically derived autologous injection therapies prepared from the patientβs own blood. Evidence for injection treatments in hip osteoarthritis is variable and benefits are typically modest and time-limited. Focused shockwave therapy (FSWT) has a limited role and may occasionally be considered where pain appears to arise from surrounding soft tissues rather than advanced joint degeneration. Surgical options, including hip replacement, are considered when symptoms remain severe despite optimal non-operative care.